Versant Capital Management, Inc - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 166 filers reported holding CARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$41
-55.4%
550.0%0.00%
Q3 2023$92
-41.0%
550.0%0.00%
Q2 2023$156
-42.2%
550.0%0.00%
Q1 2023$270
-54.3%
550.0%0.00%
Q4 2022$591
-40.9%
550.0%0.00%
Q3 2022$1,0000.0%550.0%0.00%
Q2 2022$1,00055
+243.8%
0.00%
Q4 2021$0
-100.0%
16
-97.7%
0.00%
-100.0%
Q3 2021$11,000
+266.7%
709
+208.3%
0.00%
+300.0%
Q2 2021$3,0002300.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders